Authors
Loading...
Retrospective cohort study shows lower in-hospital mortality with recombinant human soluble thrombomodulin in acute pancreatitis, suggesting clinical benefit.
Okada et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: